|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of1 , Molecular Physiology and Biophysics2 Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37205, USA
(Correspondence should be addressed to I Artner who is now at Developmental Biology Program, Stem Cell Center, Lund University, Lund 22184, Sweden; Email: isabella.artner{at}med.lu.se)
As successful generation of insulin-producing cells could be used for diabetes treatment, a concerted effort is being made to understand the molecular programs underlying islet β-cell formation and function. The closely related MafA and MafB transcription factors are both key mammalian β-cell regulators. MafA and MafB are co-expressed in insulin+β-cells during embryogenesis, while in the adult pancreas only MafA is produced in β-cells and MafB in glucagon+
-cells. MafB–/– animals are also deficient in insulin+ and glucagon+ cell production during embryogenesis. However, only MafA over-expression selectively induced endogenous Insulin mRNA production in cell line-based assays, while MafB specifically promoted Glucagon expression. Here, we analyzed whether these factors were sufficient to induce insulin+ and/or glucagon+ cell formation within embryonic endoderm using the chick in ovo electroporation assay. Ectopic expression of MafA, but not MafB, promoted Insulin production; however, neither MafA nor MafB were capable of inducing Glucagon. Co-electroporation of MafA with the Ngn3 transcription factor resulted in the development of more organized cell clusters containing both insulin- and glucagon-producing cells. Analysis of chimeric proteins of MafA and MafB demonstrated that chick Insulin activation depended on sequences within the MafA C-terminal DNA-binding domain. MafA was also bound to Insulin and Glucagon transcriptional control sequences in mouse embryonic pancreas and β-cell lines. Collectively, these results demonstrate a unique ability for MafA to independently activate Insulin transcription.
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |